HK1002030A1 - Heterocyclic derivatives of acylaminothiazole their preparation and pharmaceutical compositions containing them - Google Patents
Heterocyclic derivatives of acylaminothiazole their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HK1002030A1 HK1002030A1 HK98101048A HK98101048A HK1002030A1 HK 1002030 A1 HK1002030 A1 HK 1002030A1 HK 98101048 A HK98101048 A HK 98101048A HK 98101048 A HK98101048 A HK 98101048A HK 1002030 A1 HK1002030 A1 HK 1002030A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- acylaminothiazole
- preparation
- pharmaceutical compositions
- compositions containing
- heterocyclic derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8916122A FR2655344B1 (fr) | 1989-12-06 | 1989-12-06 | Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant. |
FR9005669A FR2661677B1 (fr) | 1990-05-04 | 1990-05-04 | Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1002030A1 true HK1002030A1 (en) | 1998-07-24 |
Family
ID=26227714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98101048A HK1002030A1 (en) | 1989-12-06 | 1998-02-11 | Heterocyclic derivatives of acylaminothiazole their preparation and pharmaceutical compositions containing them |
Country Status (20)
Country | Link |
---|---|
US (2) | US5189049A (sv) |
EP (1) | EP0432040B2 (sv) |
JP (2) | JP2760903B2 (sv) |
KR (1) | KR0147281B1 (sv) |
AR (1) | AR248138A1 (sv) |
AT (1) | ATE109145T1 (sv) |
AU (1) | AU628696B2 (sv) |
CA (1) | CA2031463C (sv) |
DE (1) | DE69011059T3 (sv) |
DK (1) | DK0432040T3 (sv) |
ES (1) | ES2057490T5 (sv) |
FI (1) | FI94249C (sv) |
GR (1) | GR3025940T3 (sv) |
HK (1) | HK1002030A1 (sv) |
HU (2) | HU218276B (sv) |
IE (1) | IE68593B1 (sv) |
IL (1) | IL96577A (sv) |
LV (1) | LV5802B4 (sv) |
MX (1) | MX9203027A (sv) |
NO (1) | NO179584C (sv) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2677356B1 (fr) * | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
US6558952B1 (en) * | 1992-12-14 | 2003-05-06 | Waratah Pharmaceuticals, Inc. | Treatment for diabetes |
FR2701708B1 (fr) * | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
FR2754258B1 (fr) | 1996-10-08 | 1998-12-31 | Sanofi Sa | Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
FR2768737B1 (fr) * | 1997-09-19 | 2000-05-19 | Sanofi Sa | Derives de carboxamidothiazoles, leur preparation, les compositions pharmaceutiques en contenant |
CO4970713A1 (es) * | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen |
HUP0004512A3 (en) | 1997-10-27 | 2003-01-28 | Agouron Pharmaceuticals Inc La | 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
FR2781227B1 (fr) * | 1998-07-20 | 2002-02-22 | Sanofi Sa | Procede pour la preparation du sel potassique du lintitript |
US20040037818A1 (en) * | 1998-07-30 | 2004-02-26 | Brand Stephen J. | Treatment for diabetes |
DE19908538A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen |
DE19908537A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
WO2000064880A1 (en) | 1999-04-22 | 2000-11-02 | Synaptic Pharmaceutical Corporation | Selective npy (y5) antagonists |
US6340683B1 (en) | 1999-04-22 | 2002-01-22 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (triazines) |
US6218408B1 (en) | 1999-06-30 | 2001-04-17 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
US6989379B1 (en) | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
US6225330B1 (en) | 1999-06-30 | 2001-05-01 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
US6222040B1 (en) | 1999-06-30 | 2001-04-24 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
US6214853B1 (en) | 1999-06-30 | 2001-04-10 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
US7273880B2 (en) | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
CA2399791A1 (en) | 2000-02-11 | 2001-08-16 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
CA2414623A1 (en) * | 2000-08-01 | 2002-02-07 | University Of Virginia Patent Foundation | Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
JP2004520345A (ja) * | 2001-01-12 | 2004-07-08 | ワラター・ファーマシューティカルズ・インク | 糖尿病を有する被験者にガストリン/cck受容体リガンド及びegf受容体リガンド組成物を用いた島細胞新生治療方法の効果持続 |
WO2002059099A1 (fr) * | 2001-01-26 | 2002-08-01 | Shionogi & Co., Ltd. | Composes cycliques presentant un agonisme envers le recepteur de thrombopoietine |
EP1357116A4 (en) * | 2001-02-02 | 2005-06-01 | Yamanouchi Pharma Co Ltd | 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF |
EP1314733A1 (en) | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
US7485655B2 (en) * | 2002-01-16 | 2009-02-03 | University Of Virginia Patent Foundation | 2-Aminothiazole allosteric enhancers of A1 adenosine receptors |
JP4120586B2 (ja) * | 2002-01-18 | 2008-07-16 | アステラス製薬株式会社 | 2−アシルアミノチアゾール誘導体又はその塩 |
US20050261298A1 (en) * | 2002-01-18 | 2005-11-24 | David Solow-Cordero | Methods of treating conditions associated with an Edg-7 receptor |
CA2477604A1 (en) | 2002-03-13 | 2003-09-25 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
EP1509087A4 (en) * | 2002-05-24 | 2005-12-21 | Waratah Pharmaceuticals Inc | TREATMENT FOR DIABETES |
EP1837031B1 (en) * | 2002-06-07 | 2009-10-14 | Waratah Pharmaceuticals, Inc. | Compositions and methods for treating diabetes |
MXPA05000130A (es) | 2002-06-27 | 2005-02-17 | Novo Nordisk As | Derivados de aril-carbonilo como agentes terapeuticos. |
US20040229810A1 (en) * | 2002-10-22 | 2004-11-18 | Antonio Cruz | Gastrin compositions and formulations, and methods of use and preparation |
US20080039379A1 (en) * | 2003-05-27 | 2008-02-14 | Waratah Pharmaceuticals, Inc. | Compositions Comprising Gastrin Compounds and Their Use in Diabetes |
US7737133B2 (en) * | 2003-09-03 | 2010-06-15 | Agi Therapeutics Ltd. | Formulations and methods of treating inflammatory bowel disease |
EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
SI1700856T1 (sl) * | 2003-12-26 | 2016-02-29 | Kyowa Hakko Kirin Co., Ltd., | Tiazolni derivat |
CN102516240A (zh) | 2004-01-06 | 2012-06-27 | 诺和诺德公司 | 杂芳基脲及其作为葡糖激酶活化剂的用途 |
MX2007001271A (es) * | 2004-08-05 | 2007-03-21 | Hoffmann La Roche | N-acil-2-aminotiazoles sustituidos. |
CA2575466A1 (en) * | 2004-08-13 | 2006-02-23 | Genentech, Inc. | Thiazole based inhibitors of atp-utilizing enzymes |
WO2006080406A1 (ja) * | 2005-01-28 | 2006-08-03 | Taisho Pharmaceutical Co., Ltd. | 三環性化合物 |
US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
EP1843734A4 (en) * | 2005-02-03 | 2008-09-10 | Signum Biosciences Inc | COMPOSITIONS AND METHOD FOR INTENSIFYING COGNITIVE FUNCTIONS |
EP1894930A4 (en) * | 2005-06-23 | 2010-06-23 | Kyowa Hakko Kirin Co Ltd | THIAZOLE DERIVATIVE |
US7999114B2 (en) | 2005-07-08 | 2011-08-16 | Novo Nordisk A/S | Dicycloalkylcarbamoyl ureas as glucokinase activators |
CA2615938C (en) | 2005-07-14 | 2014-04-29 | Novo-Nordisk A/S | Urea glucokinase activators |
KR20080074166A (ko) * | 2005-11-08 | 2008-08-12 | 아스테라스 세이야쿠 가부시키가이샤 | 혈소판감소증을 치료하는 조성물 및 방법 |
WO2007070600A2 (en) * | 2005-12-12 | 2007-06-21 | Genelabs Technologies, Inc. | N-(5-membered heteroaromatic ring)-amido anti-viral compounds |
CN101096363B (zh) * | 2006-06-27 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途 |
CA2660283C (en) * | 2006-08-08 | 2014-11-18 | Akarx, Inc. | 2-acylaminothiazole compositions and methods for increasing blood platlelet levels in humans |
WO2008084043A1 (en) | 2007-01-09 | 2008-07-17 | Novo Nordisk A/S | Urea glucokinase activators |
WO2008084044A1 (en) | 2007-01-11 | 2008-07-17 | Novo Nordisk A/S | Urea glucokinase activators |
CN102014897B (zh) | 2008-04-21 | 2015-08-05 | 西格纳姆生物科学公司 | 化合物、组合物和其制备方法 |
WO2011019990A1 (en) * | 2009-08-14 | 2011-02-17 | Eisai, Inc. | Use of e5501 for stimulating platelet production |
DE102011083271A1 (de) * | 2011-09-23 | 2013-03-28 | Beiersdorf Ag | Aromatische Amidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Aromatischen Amidothiazolen |
AU2014275643B2 (en) * | 2013-06-05 | 2018-08-09 | C&C Research Laboratories | Heterocyclic derivatives and use thereof |
EP3016951B1 (en) | 2013-07-02 | 2017-05-31 | Bristol-Myers Squibb Company | Tricyclic pyrido-carboxamide derivatives as rock inhibitors |
EP3016950B1 (en) | 2013-07-02 | 2017-06-07 | Bristol-Myers Squibb Company | Tricyclic pyrido-carboxamide derivatives as rock inhibitors |
CN109111427B (zh) * | 2017-06-22 | 2023-06-02 | 中国科学院广州生物医药与健康研究院 | 一种吲哚类化合物及其应用 |
MX2020008905A (es) | 2018-06-12 | 2020-12-03 | Vtv Therapeutics Llc | Usos terapeuticos de activadores de glucoquinasa en combinacion con insulina o analogos de insulinas. |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2340092A2 (fr) * | 1976-02-09 | 1977-09-02 | Roussel Uclaf | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
AT367871B (de) * | 1980-05-16 | 1982-08-10 | Hoerbiger Ventilwerke Ag | Anordnung zur selbsttaetigen druckentlastung von verdichtern |
FR2482596A1 (fr) * | 1980-05-19 | 1981-11-20 | Roussel Uclaf | Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament |
JPS5978171A (ja) * | 1982-10-26 | 1984-05-04 | Ikeda Mohandou:Kk | 複素環式化合物 |
FR2566405B1 (fr) * | 1984-06-25 | 1986-09-26 | Roussel Uclaf | Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus |
ATE67185T1 (de) * | 1985-07-09 | 1991-09-15 | Pfizer | Substituierte oxindol-3-carboxamine als entzuendungshemmendes und schmerzstillendes mittel. |
DE3705934A1 (de) * | 1987-02-25 | 1988-09-08 | Nattermann A & Cie | Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
US4971978A (en) * | 1987-09-21 | 1990-11-20 | Nadzan Alex M | Derivatives of D-glutamic acid and D-aspartic acid |
WO1989005812A1 (en) * | 1987-12-22 | 1989-06-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Thienodiazepine compounds and their medicinal use |
GB8804448D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8820231D0 (en) * | 1988-08-25 | 1988-09-28 | Fujisawa Pharmaceutical Co | New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same |
FR2701708B1 (fr) * | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
-
1990
- 1990-11-29 IE IE431090A patent/IE68593B1/en not_active IP Right Cessation
- 1990-12-03 FI FI905941A patent/FI94249C/sv not_active IP Right Cessation
- 1990-12-04 CA CA002031463A patent/CA2031463C/en not_active Expired - Fee Related
- 1990-12-05 DE DE69011059T patent/DE69011059T3/de not_active Expired - Fee Related
- 1990-12-05 NO NO905255A patent/NO179584C/no not_active IP Right Cessation
- 1990-12-05 AU AU67779/90A patent/AU628696B2/en not_active Ceased
- 1990-12-05 ES ES90403458T patent/ES2057490T5/es not_active Expired - Lifetime
- 1990-12-05 AR AR90318535A patent/AR248138A1/es active
- 1990-12-05 HU HU075/90A patent/HU218276B/hu not_active IP Right Cessation
- 1990-12-05 JP JP2406318A patent/JP2760903B2/ja not_active Expired - Lifetime
- 1990-12-05 EP EP90403458A patent/EP0432040B2/fr not_active Expired - Lifetime
- 1990-12-05 US US07/622,620 patent/US5189049A/en not_active Ceased
- 1990-12-05 AT AT90403458T patent/ATE109145T1/de not_active IP Right Cessation
- 1990-12-05 DK DK90403458.4T patent/DK0432040T3/da active
- 1990-12-06 IL IL9657790A patent/IL96577A/en not_active IP Right Cessation
- 1990-12-06 KR KR1019900020116A patent/KR0147281B1/ko not_active IP Right Cessation
-
1992
- 1992-06-19 MX MX9203027A patent/MX9203027A/es unknown
-
1995
- 1995-06-29 HU HU95P/P00526P patent/HU211866A9/hu unknown
- 1995-09-11 US US08/526,079 patent/USRE37094E1/en not_active Expired - Lifetime
-
1996
- 1996-07-16 LV LV960248A patent/LV5802B4/xx unknown
-
1997
- 1997-08-06 JP JP9212074A patent/JP3035253B2/ja not_active Expired - Lifetime
-
1998
- 1998-01-16 GR GR980400110T patent/GR3025940T3/el unknown
- 1998-02-11 HK HK98101048A patent/HK1002030A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1002030A1 (en) | Heterocyclic derivatives of acylaminothiazole their preparation and pharmaceutical compositions containing them | |
IL80411A (en) | Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them | |
HU896032D0 (en) | Process for the preparation of novel quinuc lidine derivatives and pharmaceutical compositions containing them | |
NZ222725A (en) | Imidazolyl-substituted derivatives of heterocyclic ketones and pharmaceutical compositions | |
NZ220345A (en) | Imidazoquinolinylether derivatives and pharmaceutical compositions containing them | |
IL92556A (en) | Aryl substituted heterocyclic alcohol derivatives, their preparation and pharmaceutical compositions containing them | |
NZ235726A (en) | Substituted pyrimidine derivatives; their preparation and pharmaceutical compositions | |
NZ229856A (en) | Derivatives of (aza)naphthalenesultam and pharmaceutical compositions; processes for preparation | |
PT86365A (en) | Process for the preparation of pyridazodiazepine derivatives and of pharmaceutical compositions containing the same | |
PT86516A (en) | Process for the preparation of heteroaryl-3-oxo-propani-nitrile derivatives and of pharmaceutical compositions containing the same | |
IL88989A0 (en) | 16-dehydro-vitamin d3 derivatives their preparation and pharmaceutical compositions containing them | |
IL87089A (en) | Derivatives of n-aminobutyl-n- phenylarylamides, their preparation and pharmaceutical compositions containing them | |
IL82205A (en) | Substituted alkane-sulfonamidophenyl derivatives and pharmaceutical compositions containing them | |
PT86407A (en) | Process for the preparation of new alkanesulfonanilide derivatives and pharmaceutical compositions comprising the same | |
PT82984A (en) | Process for the preparation of poly-4-aminopyrrole-2-carboxamido derivatives and of pharmaceutical compositions containing the same | |
HU896479D0 (en) | Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof | |
HU896612D0 (en) | Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof | |
IL114534A (en) | Heterocyclic derivatives of azolones their preparation and pharmaceutical compositions containing them | |
IL91542A0 (en) | N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them | |
PT83604A (en) | Process for the preparation of flavone derivatives and of pharmaceutical compositions containing the same | |
PT87024A (pt) | Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same | |
PT85513A (en) | Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same | |
HK1000541A1 (en) | Benzene derivatives their preparation and pharmaceutical compositions containing them | |
PT86349A (en) | Process for the preparation of triazine derivatives and of pharmaceutical compositions containing the same | |
PT85522A (en) | Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |